NCT01702376 - This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 3, 2012

Primary Completion Date

January 14, 2013

Study Completion Date

January 14, 2013

Conditions

Obstetric Labour, Premature

Interventions

DRUG

Retosiban 100 mg

Subjects will be administered with single dose of one moxifloxacin placebo tablet, one 100 mg tablet of retosiban and 7 retosiban matched placebo tablets

DRUG

Retosiban 800 mg

Subjects will be administered with single dose of one moxifloxacin placebo tablet and eight 100 mg tablets of retosiban

DRUG

Placebo

Subjects will be administered with one moxifloxacin placebo tablet and eight retosiban matched placebo tablets

DRUG

Moxifloxacin 400 mg

Subjects will be administered with one 400 mg moxifloxacin tablet and eight retosiban matched placebo tablets

Trial Locations (1)

21225

GSK Investigational Site, Baltimore